Why chemiluminescence can occupy a place in the in vitro diagnostic industry?

As the world's second largest in vitro diagnostic (IVD) market, my country's IVD industry has the characteristics of large development space and high growth rate. Among them, chemiluminescence occupies nearly 40% of the entire IVD market and is a well-deserved "flow king". Why can chemiluminescence explode in the IVD field so that it can occupy a place?

First of all, chemiluminescence has the advantages of high degree of automation, safety and stability, high accuracy, and wide detection range compared with traditional immune technology, and has become the mainstream technology of immunodiagnosis in my country. Chemiluminescence is a diagnostic method that uses specific reactions between antigens and antibodies to determine the concentration of disease markers in the body to judge the state of the human body, including enzymatic chemiluminescence (Luminol and its derivatives, AMPPD), direct chemiluminescence ( Isoluminol, acridinium ester), electrochemiluminescence (terpyridine ruthenium), etc. Chemiluminescence is currently widely used in tumors, infectious diseases, nail function, kidney function, heart disease, endocrine hormones, pregnancy testing and other directions, which can greatly meet the needs of clinical testing. These test items account for 75-80% of the total test amount and 60% of the market value; in China, these test items can account for more than 80% of the market value.

Secondly, the chemiluminescence technology did not sink fully to the primary hospitals, so there is a large space for development.

Although with the development of chemiluminescence technology, its detectable items have become more and more abundant, but at present, the chemiluminescence technology has not completely sunk to the primary hospital. At present, China's chemiluminescence instruments are mainly concentrated in tertiary and secondary hospitals, and some primary hospitals, communities, townships and other grass-roots hospitals have not been installed. With the advancement of graded diagnosis and treatment, the number of outpatient clinics continues to lower the level of these hospitals. There is a wide demand for chemiluminescence instruments and reagents, that is to say, there is still huge room for development in domestic chemiluminescence.

In summary, the reason why chemiluminescence is becoming more and more popular in the in vitro diagnostic industry is mainly due to two reasons. First, chemiluminescence has a large market in China because of its special advantages. Second, in the future, chemiluminescence will further sink to the grassroots, covering the needs of hospitals at all levels, and there is great room for development.

Since 2005, Desheng has been researching and producing various raw materials for blood collection tube additives, biological buffers, chemiluminescent reagents, etc. It is hoped that with the joint efforts of Desheng people, it will gain its own world in the in vitro diagnostic industry.